Scientists create world’s first mini-brain with working blood-brain barrier
UC, Cincinnati Children's researcher featured in Interesting Engineering
Interesting Engineering recently highlighted research led by University of Cincinnati and Cincinnati Children's Hospital researcher Ziyuan Guo that developed the first human mini-brain that incorporates a fully functional blood-brain barrier (BBB).
In collaboration with researchers at the Mayo Clinic and University of California San Diego, the researchers said this breakthrough could help accelerate the understanding of and development of novel treatments for many brain disorders including cancer, Alzheimer's disease and Parkinson's disease.
“Lack of an authentic human BBB model has been a major hurdle in studying neurological diseases," said lead author Ziyuan Guo, PhD, assistant professor in the Department of Pediatrics in UC's College of Medicine and researcher at Cincinnati Children's. "Our breakthrough involves the generation of human BBB organoids from human pluripotent stem cells, mimicking human neurovascular development to produce a faithful representation of the barrier in growing, functioning brain tissue. This is an important advance because animal models we currently use in research do not accurately reflect human brain development and BBB functionality.
"“Now, through stem cell bioengineering, we have developed an innovative platform based on human stem cells that allows us to study the intricate mechanisms governing BBB function and dysfunction," Guo continued. "This provides unprecedented opportunities for drug discovery and therapeutic intervention."
Read the Interesting Engineering article.
The research was also featured in Drug Target Review. Read the Drug Target Review article.
Featured photo at top of neurons. photo/Imaginima/iStock.
Related Stories
The Last Show with David Cooper discusses AI in education with UC’s Joshua Lambert
April 12, 2026
The Last Show with David Cooper, a global news podcast, featured Joshua Lambert, PhD, a professor and biostatistician in UC College of Nursing to discuss his latest research on using artificial intelligence for student advising.
UC enrolls first patients in clinical trial for prosthetic joint infections
April 10, 2026
The University of Cincinnati has enrolled the first patients in Peptilogics’ RETAIN clinical trial, testing an investigational drug for prosthetic joint infections after total knee replacement to reduce repeat surgeries and infection recurrence.
On the Green dining hall earns national 4-Star Green Restaurant Certification
April 9, 2026
On the Green has earned a 4-Star Certified Green Restaurant designation from the Green Restaurant Association, achieving 365.5 GreenPoints for verified efforts in areas like waste reduction, water efficiency and sustainable food practices.